These findings demonstrate that loss of STAT2 impairs both cell proliferation and tumor growth, whereas loss of IFNAR1 does not, further supporting the notion that STAT2 promotes tumorigenicity through mechanisms distinct from canonical IFNAR1 signaling. The gene discussed is IFNAR1; the disease is neoplasm.